BRCA2 and ovarian cancer: This study estimated the prevalence of BRCA1 and BRCA2 PSVs among female patients ≥18 years of age that are diagnosed with ovarian cancer, peritoneal cancer, and fallopian tube cancer in the Gulf region, with the aim of informing clinical practice and improving clinical treatments in the future.